Details for Patent: 7,166,722
✉ Email this page to a colleague
Which drugs does patent 7,166,722 protect, and when does it expire?
Patent 7,166,722 protects FOTIVDA and is included in one NDA.
This patent has ten patent family members in nine countries.
Summary for Patent: 7,166,722
| Title: | N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxaz- olyl)urea salt in crystalline form |
| Abstract: | The present invention provides a crystal of a pharmaceutically acceptable salt of N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl- -3-isoxazolyl) urea. This crystal of salt is usable for the therapy of a disease selected from the group consisting of tumors, diabetic retinopathy, chronic rheumatism, psoriasis, atherosclerosis, Kaposi's sarcoma, and exudation type age-related maculopathy, and has characteristics suitable for applications of oral pharmaceutical preparations. |
| Inventor(s): | Matsunaga; Naoki (Gunma-Ken, JP), Yoshida; Satoshi (Gunma-Ken, JP), Yoshino; Ayako (Gunma-Ken, JP), Nakajima; Tatsuo (Gunma-Ken, JP) |
| Assignee: | Kirin Beer Kabushiki Kaisha (Tokyo-To, JP) |
| Application Number: | 10/532,104 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 7,166,722
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aveo Pharms | FOTIVDA | tivozanib hydrochloride | CAPSULE;ORAL | 212904-001 | Mar 10, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| Aveo Pharms | FOTIVDA | tivozanib hydrochloride | CAPSULE;ORAL | 212904-002 | Mar 10, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,166,722
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2002-306101 | Oct 21, 2002 |
| PCT Information | |||
| PCT Filed | October 21, 2003 | PCT Application Number: | PCT/JP03/13439 |
| PCT Publication Date: | April 29, 2004 | PCT Publication Number: | WO2004/035572 |
International Family Members for US Patent 7,166,722
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 374199 | ⤷ Try a Trial | |||
| Australia | 2003301430 | ⤷ Try a Trial | |||
| Germany | 60316590 | ⤷ Try a Trial | |||
| Denmark | 1559715 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
